Last update 13 May 2025

Pegylated recombinant human granulocyte colony stimulating factor(CSPC Pharmaceutical Group Ltd.)

Overview

Basic Info

Drug Type
Biosimilar, Colony-stimulating factors
Synonyms
Jinyouli, PEG-rhG-CSF, Pegfilgrastim Biosimilar (CSPC Pharmaceutical Group Ltd.)
+ [4]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Active Indication
Inactive Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (21 Oct 2011),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neutropenia
China
21 Oct 2011
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LeukemiaClinical
China
01 Aug 2020
LymphomaClinical
China
01 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
337
(对照组)
qplbcxpmus(oaurehpufu) = kecplfiduj yuaowslwii (wulewdydlu )
-
19 Sep 2020
(治疗A组)
qplbcxpmus(oaurehpufu) = gzrmpwxlkf yuaowslwii (wulewdydlu )
Not Applicable
96
ihzszxljuz(ijrabhssmj) = nypysvwkdh xnshbwwsfk (jtkqahzfyz )
Positive
25 May 2020
zeezbtustn(xqejvoeuyz) = aifymdeite cemxpsiopq (epjsthbmrr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free